Larazotide


CAS No. : 258818-34-7

258818-34-7
Price and Availability of CAS No. : 258818-34-7
Size Price Stock
5mg $85 In-stock
10mg $136 In-stock
25mg $300 In-stock
50 mg Get quote
100 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-106268
M.Wt: 725.83
Formula: C32H55N9O10
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 258818-34-7 :

Larazotideis a peptide which is an orally active zonulin antagonist. Larazotide shows antiviral activity to varicella-zoster virus (VZV) with EC50s of 44.14 and 59.06 μM for strain OKA and 07-1, respectively. Larazotide can be used for the research of celiac disease and infection[1][2]. In Vitro: Larazotide (1-100 μM; 5 d) affects Vero cell growth[1].
Larazotide (1-100 μM; 3 d) shows antiviral activity to varicella-zoster virus (VZV) with EC50s of 44.14 and 59.06 μM for strain OKA and 07-1, respectively[1].
Larazotide (1 and 3 mM; 72 h) inhibits cytokine-induced tight junction permeability in Caco-2 cells[2].
Larazotide (100 μM; 3 h) inhibits gliadin translocation across Caco-2 monolayers[2].
Larazotide (12.5 mM; 1 h) inhibits PTG-induced ZO-1 redistribution and actin cytoskeletal rearrangement in IEC6 cells[2]. In Vivo: Larazotide (250 μg; i.p. twice a week for 7 weeks) inhibits intestinal permeability in gluten-sensitive transgenic mice[1].

Your information is safe with us.